Histological and Immunohistochemical Staining

XW Xiexing Wu
YL Yijie Liu
JD Jiacheng Du
XL Xiaoping Li
JL Jiayi Lin
LN Li Ni
PZ Pengfei Zhu
HZ Hong Zhou
FK Fanchen Kong
HY Huilin Yang
DG Dechun Geng
HM Haiqing Mao
ask Ask a question
Favorite

Following euthanasia, all IVDs were obtained from each rat, fixed in 4% formaldehyde solution for 48 h, decalcified by 10% ethylenediaminetetraacetic acid (EDTA, Sigma) for 40 days, and finally embedded in paraffin. The paraffin-embedded IVD specimens were cut into 5-μm coronal sections with intact structures. Parts of these specimens were stained with safranin-O fast green and hematoxylin and eosin (H&E). The method established by Masuda was used to assess the histological morphology of the specimens (Table 2; Masuda et al., 2005).

Definition of histological scale.

TRAP staining was performed with a TRAP staining kit (#387A, Sigma-Aldrich, St. Louis, MO, United States). Dark purple particles were considered osteoclasts. A new method by Sawyer was used to quantify TRAP-positive cells (Sawyer et al., 2003). Immunohistochemical staining was used to observe specific expression of anti-Col-II (1:500, ab34712, Abcam), MMP13 (1:200, ab219620, Abcam), IL-1β (1:500, ab205924, Abcam), anti-p-P65 (1:200, ab16502, Abcam), and RANKL (1:500, ab239607, Abcam) in the rat IVD tissues. After being dewaxed, gradient hydrating and protease-modifying, sections were blocked with 5% horse serum and then incubated with the primary antibody overnight at 4°C. Sections were then washed with PBS, then successively incubated with secondary antibody and tertiary antibodies for 30 min, stained with 3,3′-diaminobenzidine tetrahydrochloride, and finally counterstained with hematoxylin. All images were taken using a high-resolution microscope. The positive staining cells and areas were analyzed using ImageJ software.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A